These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 9469432

  • 41. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18.
    Nagai H, Hara I, Horikawa T, Fujii M, Kurimoto M, Kamidono S, Ichihashi M.
    Cancer Invest; 2000; 18(3):206-13. PubMed ID: 10754989
    [Abstract] [Full Text] [Related]

  • 42. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells.
    Fresa KL, Murasko DM.
    Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213
    [Abstract] [Full Text] [Related]

  • 43. The effect of NK cell activation by tumor cells on antigen-specific antibody responses.
    Koh CY, Yuan D.
    J Immunol; 1997 Nov 15; 159(10):4745-52. PubMed ID: 9366398
    [Abstract] [Full Text] [Related]

  • 44. Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.
    Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L.
    J Immunother Emphasis Tumor Immunol; 1993 Oct 15; 14(3):191-201. PubMed ID: 7905286
    [Abstract] [Full Text] [Related]

  • 45. Interferon-gamma-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-gamma-inducing factor in macrophages elicited by allografted tumor cells.
    Sanchez-Bueno A, Verkhusha V, Tanaka Y, Takikawa O, Yoshida R.
    Biochem Biophys Res Commun; 1996 Jul 16; 224(2):555-63. PubMed ID: 8702426
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar 16; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ, Reome JB, Dutton RW.
    Clin Immunol; 2001 Jan 16; 98(1):70-84. PubMed ID: 11141329
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov 16; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 56. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy.
    Pappo I, Tahara H, Robbins PD, Gately MK, Wolf SF, Barnea A, Lotze MT.
    J Surg Res; 1995 Feb 16; 58(2):218-26. PubMed ID: 7861776
    [Abstract] [Full Text] [Related]

  • 57. Distinct antitumor mechanisms of recombinant interleukin-2 on recombinant interleukin-2-activated killer-sensitive and -resistant murine tumors.
    Maekawa R, Kitagawa T, Koizumi K, Sato K, Homma M.
    J Biol Response Mod; 1989 Dec 16; 8(6):676-90. PubMed ID: 2600605
    [Abstract] [Full Text] [Related]

  • 58. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice.
    Heremans H, Dillen C, van Damme J, Billiau A.
    Eur J Immunol; 1994 May 16; 24(5):1155-60. PubMed ID: 8181525
    [Abstract] [Full Text] [Related]

  • 59. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages.
    Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E, Malorni W, Nicaise P, Wolf SF, Belardelli F, Gessani S.
    J Immunol; 1997 Oct 01; 159(7):3490-7. PubMed ID: 9317148
    [Abstract] [Full Text] [Related]

  • 60. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
    Choi BK, Kim YH, Kim CH, Kim MS, Kim KH, Oh HS, Lee MJ, Lee DK, Vinay DS, Kwon BS.
    J Immunol; 2010 Aug 01; 185(3):1404-11. PubMed ID: 20610645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.